| Disease | BIOTINIDASE DEFICIENCY |
| Synonym | MULTIPLE CARBOXYLASE DEFICIENCY, LATE ONSET; BIOTINIDASE DEFICIENCY |
| OMIM | 253260
Comprehensive, authoritative, and timely compendium of human genes and genetic phenotypes
OMIM = Online Medalian Inheritance of Men |
| Orphanet |
Short summery, also for non professionals on www.orpha.net
|
|---|
| Enzyme | biotinidase
Detailed enzyme information on www.expacy.ch
|
| Gene locus |
3p25
|
| genetests.org |
search search on genetest.org by MIM 253260
search search on genetest.org by BIOTINIDASE+DEFICIENCY
Testing - View a listing of laboratories that provide clinical testing for this disorder
Reviews - Read the GeneReview for this disorder
Resources - View and p
|
| Summary | 1:60000 autosomal recessive preliminary studies fail to demonstrate clear genotype-phenotype correlations [Hymes J; 2001] |
| Clinical symptoms |
- alopecia
- ataxia
- cerebral atrophy
- coma
- conjunctivitis
- early death
- eczematoid skin rush
- encephalopathy
- fatigue, severe or unusual
- fetal akinesia/hypokinesia sequence
- hair loss
- hearing defect, deafness
- hyperammonemia
- hypertonia, spasticity
- hypotonia
- infantile spasms
- infections (severe or recurrent)
- ketosis
- lactic acidosis
- metabolic acidosis
- motor retardation
- muscle weakness
- onset, adolescent
- onset, child
- onset, infant
- onset, newborn
- optic atrophy
- seborrhoic skin rush
- seizures
- spastic diplegia/quadriplegia
- speech development, delayed, abnormal
- spinal cord demyelinisation
- stridor
- tachypnea, hyperpnea, dyspnea, respiratory distress
- vomiting
|
|---|
Abnormal Findings in blood |
- 3-Hydroxyisovalerylcarnitine (C5-OH)
| Significant : - increased
- Ammonia
Normal: 25.00-80.00 µmol/l
| Significant : 150.00-200.00 µmol/l
- Ketone bodies
| Significant : - increased
- Lactate, fed state
Normal: 0.90-1.80 mmol/l
| Significant : 1.00-6.00 mmol/l
- pH
Normal: 7.35-7.45 no unit
| Significant : 7.00-7.40 no unit
|
Abnormal Findings in plasma |
- 3-Hydroxyisovaleric acid
Normal: 0.00-19.00 µmol/l
| Significant : 10.00-166.00 µmol/l
|
Abnormal Findings in spinal fluid |
- 2-Hydroxybutyrate
Normal: 11.00-86.00 µmol/l
| Significant : 17.00-394.00 µmol/l
- 3-Hydroxybutyrate
Normal: 20.00-60.00 µmol/l
| Significant : 7.00-882.00 µmol/l
- 3-Hydroxyisovaleric acid
Normal: 0.00-18.00 µmol/l
| Significant : 10.00-300.00 µmol/l
- 3-Hydroxypropionic acid
Normal: 0.00-9.50 µmol/l
| Significant : 0.00-15.00 µmol/l
- Citrate
Normal: 90.00-590.00 µmol/l
| Significant : 60.00-170.00 µmol/l
- Lactate, spinal fluid
Normal: 0.50-2.10 mmol/l
| Significant : 1.70-12.00 mmol/l
|
Abnormal Findings in urine |
- 3-Hydroxyisovaleric acid
Normal: 0.00-46.00 mmol/mol creatinine
| Significant : 50.00-500.00 mmol/mol creatinine
- 3-Hydroxypropionic acid
Normal: 3.00-10.00 mmol/mol creatinine
| Significant : 20.00-500.00 mmol/mol creatinine
- 3-Methylcrotonylglycine
Normal: 0.00-2.00 mmol/mol creatinine
| Significant : 5.00-50.00 mmol/mol creatinine
- Acylcarnitin
| Significant : - increased
- Lactate
Normal: 0.00-25.00 mmol/mol creatinine
| Significant : 100.00-75000.00 mmol/mol creatinine
- Methylcitric acid
Normal: 2.00-12.00 mmol/mol creatinine
| Significant : 10.00-50.00 mmol/mol creatinine
|
| Treatment |
|
| Picture 61 |
Infant with partial biotinidase deficiency showing only minor skin changes
|
| Literature | There are 21 publications available.
Click here to open the relevant BIOTINIDASE DEFICIENCY publications |
Ramedis Case reports with long term followup | There are 31 patient data available.
Click here to open the list of BIOTINIDASE DEFICIENCY patients documented in Ramedis database |